Efficacy and Tolerability of SPN-804, a Novel, Once-Daily, Extended-Release Formulation of Oxcarbazepine: Adjunctive Treatment of Refractory Partial Seizures in a North American Subpopulation

被引：0

作者：

Johnson, Janet ^{[1
]}

Brittain, Scott ^{[1
]}

Louro, Dawn ^{[1
]}

机构：

[1] Supernus Pharmaceut Inc, Rockville, MD USA

来源：

NEUROLOGY | 2013年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P02213

引用

页数：1

共 40 条

[21] Long-term efficacy and safety of adjunctive extended-release oxcarbazepine (Oxtellar XR®) in adults with partial-onset seizures
Chung, S. S.
Johnson, J. K.
Brittain, S. T.
Baroldi, P.
ACTA NEUROLOGICA SCANDINAVICA, 2016, 133 (02): : 124 - 130
[22] EFFICACY AND TOLERABILITY OF ONCE-DAILY GABAPENTIN EXTENDED-RELEASE(G-ER)FOR THE TREATMENT OF POSTHERPETIC NEURALGIA IN PATIENTS AT LEAST 65 YEARS OLD
Sweeney, Michael
Sathyanarayana, Rekha
JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 : S161 - S161
[23] Once-daily extended-release levetiracetam as add-on therapy in patients with refractory partial-onset seizures:: Double blind, placebo-controlled trial
Peltola, Jukka
Coetzee, Christo
Jimenez, Fiacro
Litovchenko, Tetyana
Sridharan, R.
Zaslavskiy, Leonid
Sykes, Deanne
Lu, Sarah
NEUROLOGY, 2008, 70 (11) : A73 - A73
[24] Dose conversion and titration with a novel, once-daily, OROS® osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain
Palangio, M
Northfelt, DW
Portenoy, RK
Brookoff, D
Doyle, RT
Dornseif, BE
Damask, MC
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2002, 23 (05) : 355 - 368
[25] Efficacy of once-daily extended-release topiramate (USL255): A subgroup analysis based on the level of treatment resistance
Hogan, R. Edward
Blatt, Ilan
Lawson, Balduin
Nagaraddi, Venkatesh
Fakhoury, Toufic A.
Anders, Bob
Clark, Annie M.
Laine, Dawn
Halvorsen, Mark B.
Chung, Steve S.
EPILEPSY & BEHAVIOR, 2014, 41 : 136 - 139
[26] Efficacy and Safety of Once-Daily Extended-Release Centanafadine for the Treatment of ADHD in Children Aged 6-12 Years
Ward, C. L.
Jin, N.
Turkoglu, O.
Skubiak, T.
Childress, A.
Mattingly, G.
van Stralen, J.
ANNALS OF NEUROLOGY, 2025, 96 : S93 - S93
[27] Efficacy and Safety of Once-Daily Extended-Release Centanafadine for the Treatment of ADHD in Adolescents Aged 13-17 Years
Ward, C. L.
Jin, N.
Turkoglu, O.
Skubiak, T.
Childress, A.
Mattingly, G.
van Stralen, J.
ANNALS OF NEUROLOGY, 2025, 96 : S96 - S96
[28] Efficacy of once-daily extended-release ciprofloxacin for treatment of uncomplicated urinary tract infections due to Staphylococcus saprophyticus.
Oberoi, M
Haverstock, D
Cyrus, P
Kowalsky, S
JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (02) : S399 - S399
[29] Comparative tolerability, safety and efficacy of tablet formulations of twice-daily clarithromycin 250 mg versus once-daily extended-release clarithromycin 500 mg in pediatric and adolescent patients
Block, Stan L.
CLINICAL PEDIATRICS, 2006, 45 (07) : 641 - 648
[30] Perampanel, an AMPA Receptor Antagonist, as Adjunctive Once-Daily Therapy in Patients with Refractory Partial-Onset Seizures: Safety and Tolerability Analysis from a Multicenter, Randomized Phase III Trial
Krauss, Gregory L.
Serratosa, Jose M.
Villanueva, Vicente E.
Endziniene, Milda
Hong, Zhen
French, Jacqueline
Yang, Haichen
Squillacote, David
Zhu, Jin
Laurenza, Antonio
NEUROLOGY, 2011, 76 (09) : A291 - A292

← 1 2 3 4 →